The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.
Related Posts
Help The Times Report on Optum-Controlled Doctor’s Offices
The Times wants to hear from patients and providers about medical practices affiliated with Optum, a subsidiary of UnitedHealth Group.…
Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.
As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.
Life Expectancy in California Has Not Rebounded After Covid
The state’s life expectancy was lower in 2024 than in 2019, according to an analysis, but primarily as a result…